1Kohom EI, Goldstein DP, Hancock BW, et al. Combining the staging system of the international federation of gynecology and obstetrics with the scoring system of the world health organization for trophoblastic neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society [ J ]. Int J Gynecol Cancer, 2000,10 : 84-88.
2Kohom EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease:description and critical assessment[J]. Int J Gynecol Cancer, 2001,11:73-77.
3Ngan S, Seckl MJ. Gestational trophoblastic neoplasia management : an update[J]. Curr Opion Oncol,2007 ,19 :486-491.
4Newlands ES, Bagshawe KD, Begent RHJ, et al. Results with EMA/CO ( etopside, methotrexate, actinomycin, cyclophosphamide and vincristine ) regimen in high-risk gestational trophoblastic tumours, 1970 to 1989[J]. Br J Obstet Gynecol, 1991, 98:550-557.
7Wan X, Xiang Y, Yang X, et al. Efficacy of the FAEV regimen in the treatment of high risk, drug resistant gestafional trophoblastic tumour[ J]. J Reprod Med,2007,52:941-944.
8Soper JT, Evans AC, Clarke-Pearson D, et al. Alternating weekly chemotherapy with etopsid cyclophosphamide vincristine for high-risk gestational trophoblastic disease[ J]. Obstet Gynecol, 1994, 83 : 113-117.
10Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycine D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumours refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumours [J]. J Clin Oncol, 2000,18 : 854- 859.
3Lurain JR. Pharmacotherapy of gestational trophoblastic disease [J] .Expert Opin Pharmacother, 2003, 4 (11): 2005 - 2017.
4Benedet JL, Bender H, Jones H 3rd. Staging classifications and clinical practice guidelines for gynecologic cancers. FIGO Committee on Gynecologic Oncology [ J] . Int J Gynecol Ob- stet, 2000, 70:207-312.
5Ohira S, Shiozawa T. Diagnosis trophoblastic tumor [ J] . and treatment of epithelioid Rinsho, 2012, 70 (SupplNihon 4) : 744 - 748.
6Chalouhi GE, Golfier F, Soignon P, et al. Methotrexate for 2000 FIGO low - risk gestational trophoblastic neoplasia pa- tients: efficacy and toxicity [ J] . Am J Obstet Gynecol, 2009, 200 : 643 - 646.
7Wan X, Xiang Y, Yang X, et al. Efficacy of the FAEV reg- imen in the treatment of high - risk, drug - resistant gesta- tional trophoblastic tumor [ J] . J Reprod Med, 2007, 52 (10) : 941 -944.
